N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide

C121H178F4N26O27S11 — CID 158649716

IUPACN-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide
SMILESCC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-c2ccccc2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2scnc2c1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1cccc2nsnc12.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ncccn1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ncncn1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1nnc(-c2ccc(F)cc2)s1.COc1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)CCCCNS(=O)(=O)C(C)C
InChIInChI=1S/C20H26N2O3S.C17H28N2O6S.C16H23F3N2O3S.C16H21FN4O3S2.C15H21N3O3S2.C14H20N4O3S2.C12H20N4O3S.C11H19N5O3S/c1-16(2)26(24,25)21-15-7-6-10-20(23)22-19-13-11-18(12-14-19)17-8-4-3-5-9-17;1-12(2)26(21,22)18-9-7-6-8-16(20)19-13-10-14(23-3)17(25-5)15(11-13)24-4;1-11(2)25(23,24)20-9-5-4-6-15(22)21-14-8-7-13(10-12(14)3)16(17,18)19;1-11(2)26(23,24)18-10-4-3-5-14(22)19-16-21-20-15(25-16)12-6-8-13(17)9-7-12;1-11(2)23(20,21)17-8-4-3-5-15(19)18-12-6-7-14-13(9-12)16-10-22-14;1-10(2)23(20,21)15-9-4-3-8-13(19)16-11-6-5-7-12-14(11)18-22-17-12;1-10(2)20(18,19)15-9-4-3-6-11(17)16-12-13-7-5-8-14-12;1-9(2)20(18,19)15-6-4-3-5-10(17)16-11-13-7-12-8-14-11/h3-5,8-9,11-14,16,21H,6-7,10,15H2,1-2H3,(H,22,23);10-12,18H,6-9H2,1-5H3,(H,19,20);7-8,10-11,20H,4-6,9H2,1-3H3,(H,21,22);6-9,11,18H,3-5,10H2,1-2H3,(H,19,21,22);6-7,9-11,17H,3-5,8H2,1-2H3,(H,18,19);5-7,10,15H,3-4,8-9H2,1-2H3,(H,16,19);5,7-8,10,15H,3-4,6,9H2,1-2H3,(H,13,14,16,17);7-9,15H,3-6H2,1-2H3,(H,12,13,14,16,17)
InChIKeyIBJZGKYKTNLHSR-UHFFFAOYSA-N
MW2857.64 g/mol
LogP18.25
Rot. Bonds69

About N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide

N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide (PubChem CID 158649716) has the molecular formula C121H178F4N26O27S11 and a molecular weight of 2857.64 g/mol. Its IUPAC name is N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide.

Molecular Properties

Compound NameN-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide
PubChem CID158649716
Molecular FormulaC121H178F4N26O27S11
Molecular Weight2857.64 g/mol
Exact Mass2855.02
IUPAC NameN-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide
SMILESCC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-c2ccccc2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2scnc2c1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1cccc2nsnc12.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ncccn1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ncncn1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1nnc(-c2ccc(F)cc2)s1.COc1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)CCCCNS(=O)(=O)C(C)C
InChIInChI=1S/C20H26N2O3S.C17H28N2O6S.C16H23F3N2O3S.C16H21FN4O3S2.C15H21N3O3S2.C14H20N4O3S2.C12H20N4O3S.C11H19N5O3S/c1-16(2)26(24,25)21-15-7-6-10-20(23)22-19-13-11-18(12-14-19)17-8-4-3-5-9-17;1-12(2)26(21,22)18-9-7-6-8-16(20)19-13-10-14(23-3)17(25-5)15(11-13)24-4;1-11(2)25(23,24)20-9-5-4-6-15(22)21-14-8-7-13(10-12(14)3)16(17,18)19;1-11(2)26(23,24)18-10-4-3-5-14(22)19-16-21-20-15(25-16)12-6-8-13(17)9-7-12;1-11(2)23(20,21)17-8-4-3-5-15(19)18-12-6-7-14-13(9-12)16-10-22-14;1-10(2)23(20,21)15-9-4-3-8-13(19)16-11-6-5-7-12-14(11)18-22-17-12;1-10(2)20(18,19)15-9-4-3-6-11(17)16-12-13-7-5-8-14-12;1-9(2)20(18,19)15-6-4-3-5-10(17)16-11-13-7-12-8-14-11/h3-5,8-9,11-14,16,21H,6-7,10,15H2,1-2H3,(H,22,23);10-12,18H,6-9H2,1-5H3,(H,19,20);7-8,10-11,20H,4-6,9H2,1-3H3,(H,21,22);6-9,11,18H,3-5,10H2,1-2H3,(H,19,21,22);6-7,9-11,17H,3-5,8H2,1-2H3,(H,18,19);5-7,10,15H,3-4,8-9H2,1-2H3,(H,16,19);5,7-8,10,15H,3-4,6,9H2,1-2H3,(H,13,14,16,17);7-9,15H,3-6H2,1-2H3,(H,12,13,14,16,17)
InChIKeyIBJZGKYKTNLHSR-UHFFFAOYSA-N
XLogP18.25
TPSA758.75 Ų
H-Bond Donors16
H-Bond Acceptors40
Rotatable Bonds69
Heavy Atoms189
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002857.64
LogP ≤ 518.25
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?
The IUPAC name of N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide (CID 158649716) is N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide.
What is the SMILES notation for N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?
The canonical SMILES for N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide is CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(-c2ccccc2)cc1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ccc2scnc2c1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1cccc2nsnc12.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ncccn1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1ncncn1.CC(C)S(=O)(=O)NCCCCC(=O)Nc1nnc(-c2ccc(F)cc2)s1.COc1cc(NC(=O)CCCCNS(=O)(=O)C(C)C)cc(OC)c1OC.Cc1cc(C(F)(F)F)ccc1NC(=O)CCCCNS(=O)(=O)C(C)C.
What is the InChIKey of N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?
The InChIKey is IBJZGKYKTNLHSR-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H26N2O3S.C17H28N2O6S.C16H23F3N2O3S.C16H21FN4O3S2.C15H21N3O3S2.C14H20N4O3S2.C12H20N4O3S.C11H19N5O3S/c1-16(2)26(24,25)21-15-7-6-10-20(23)22-19-13-11-18(12-14-19)17-8-4-3-5-9-17;1-12(2)26(21,22)18-9-7-6-8-16(20)19-13-10-14(23-3)17(25-5)15(11-13)24-4;1-11(2)25(23,24)20-9-5-4-6-15(22)21-14-8-7-13(10-12(14)3)16(17,18)19;1-11(2)26(23,24)18-10-4-3-5-14(22)19-16-21-20-15(25-16)12-6-8-13(17)9-7-12;1-11(2)23(20,21)17-8-4-3-5-15(19)18-12-6-7-14-13(9-12)16-10-22-14;1-10(2)23(20,21)15-9-4-3-8-13(19)16-11-6-5-7-12-14(11)18-22-17-12;1-10(2)20(18,19)15-9-4-3-6-11(17)16-12-13-7-5-8-14-12;1-9(2)20(18,19)15-6-4-3-5-10(17)16-11-13-7-12-8-14-11/h3-5,8-9,11-14,16,21H,6-7,10,15H2,1-2H3,(H,22,23);10-12,18H,6-9H2,1-5H3,(H,19,20);7-8,10-11,20H,4-6,9H2,1-3H3,(H,21,22);6-9,11,18H,3-5,10H2,1-2H3,(H,19,21,22);6-7,9-11,17H,3-5,8H2,1-2H3,(H,18,19);5-7,10,15H,3-4,8-9H2,1-2H3,(H,16,19);5,7-8,10,15H,3-4,6,9H2,1-2H3,(H,13,14,16,17);7-9,15H,3-6H2,1-2H3,(H,12,13,14,16,17).
What are the key properties of N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide?
N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide has a molecular weight of 2857.64 g/mol, XLogP of 18.25, 69 rotatable bonds, 16 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2,1,3-benzothiadiazol-4-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-(1,3-benzothiazol-5-yl)-5-(propan-2-ylsulfonylamino)pentanamide;N-[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-5-(propan-2-ylsulfonylamino)pentanamide;N-[2-methyl-4-(trifluoromethyl)phenyl]-5-(propan-2-ylsulfonylamino)pentanamide;N-(4-phenylphenyl)-5-(propan-2-ylsulfonylamino)pentanamide;5-(propan-2-ylsulfonylamino)-N-pyrimidin-2-ylpentanamide;5-(propan-2-ylsulfonylamino)-N-(1,3,5-triazin-2-yl)pentanamide;5-(propan-2-ylsulfonylamino)-N-(3,4,5-trimethoxyphenyl)pentanamide is sourced from PubChem (CID 158649716), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).